GlobeNewswire by notified

Kepler Communications Announces Testing of ÆTHER™ Network with Spire Global, Inc.

Share

Toronto, Ontario, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Kepler Communications announced today the signing of a contract with Spire Global, Inc. (“Spire”) (NYSE: SPIR), a leading global provider of space-based data, analytics, and space services, to launch a test of Kepler’s ÆTHER network. This will serve as an initial test bed for Kepler’s ÆTHER service and will also help Spire evaluate how the technology can support its goal to collect accurate, timely and global data.

Announced at Satellite 2021, ÆTHER is the fulfilment of Kepler’s mission to enable the space economy by delivering the infrastructure for always-on, real-time connectivity to space-based assets. With ÆTHER, Kepler will solve one of the key challenges facing low earth orbit missions, which is limited connectivity with Earth, by relaying data through the ÆTHER network. Without an always-on, real-time communications link, operators must wait until the satellite is above a ground station to learn about the health of the asset, confirm satellite location, or identify anomalous behavior. In addition, the value of the data collected by satellites diminishes with time until it eventually reaches Earth. By providing an always on, real-time link to satellites, Kepler’s ÆTHER service delivers an important new service to the space community, while opening a new market for Kepler’s satellite technology.

Spire will host Kepler's ÆTHER product aboard an upcoming Spire nanosatellite. The communications system has a small form factor and is easily integrated. This is driven by Kepler's unique patented LEO architecture.

“At Spire we are always on the lookout for products and technologies that enhance our ability to deliver highly impactful data to our customers in a timely manner,” said Jeroen Cappaert, Chief Technology Officer and Co-Founder of Spire.

“This initiative with Spire is an early validation of the value and importance of the ÆTHER program for Kepler. Spire is a recognized pioneer in the market and understands the advantage of improving communications with their space assets. We look forward to demonstrating our capabilities with them and many other customers soon to be announced as we deliver on our mission of connecting the space economy," said Mina Mitry, Kepler’s CEO & Co-Founder.

The initial test aboard a Spire satellite is due to launch in Q4 2022. Ahead of this initial launch, Kepler Communications will be conducting on-orbit testing of the ÆTHER hardware in the first quarter of 2022, onboard two new Kepler satellites. Details on the launch and test results will be announced at a future date.

ABOUT KEPLER COMMUNICATIONS Inc.

Kepler is a satellite telecommunications provider based in Canada, backed by Tribe Capital, Canaan, Costanoa Ventures, IA Ventures and other leading investors. Kepler’s mission is to bring the Internet outside of Earth.  To this end, Kepler is building an in-space telecommunications network through an incremental deployment of products and technologies. The first to launch and operate a Ku-band satellite service in Low Earth Orbit, Kepler has expanded its capabilities with the successful launch of 15 satellites in their constellation and the commissioning of a satellite production facility at their Toronto headquarters.  For more information visit www.kepler.space and @KeplerComms.

ABOUT SPIRE GLOBAL, INC.

Spire (NYSE:SPIR) is a leading global provider of space-based data, analytics, and space services, offering access to unique datasets and powerful insights about Earth from the ultimate vantage point so that organizations can make decisions with confidence, accuracy, and speed. Spire uses one of the world’s largest multi-purpose satellite constellations to source hard to acquire, valuable data and enriches it with predictive solutions. Spire then provides this data as a subscription to organizations around the world so they can improve business operations, decrease their environmental footprint, deploy resources for growth and competitive advantage, and mitigate risk. Spire gives commercial and government organizations the competitive advantage they seek to innovate and solve some of the world’s toughest problems with insights from space. Spire has offices in San Francisco, Boulder, Washington, D.C., Ontario, Glasgow, Luxembourg, and Singapore. To learn more, visit http://www.spire.com.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares24.4.2024 03:36:40 CEST | Press release

BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced the pricing of an underwritten public offering of 10,810,810 American Depositary Shares (“ADSs”), each representing one ordinary share, at a price to the public of $9.25 per ADS. The aggregate gross proceeds to Centessa from this offering are expected to be approximately $100 million, before deducting underwriting discounts and commissions and offering expenses payable by Centessa. All ADSs sold in the offering were offered by Centessa. The offering is expected to close on or about April 26, 2024, subject to customary closing conditions. Centessa has also granted the underwriters a 30-day option to purchase up to an additional 1,621,621 ADSs at the public offering price, less underwriting discounts and commissions. Goldman Sachs, Leerink Partners, Eve

UK businesses must prioritise payment technology to build customer loyalty and stay competitive: New research from Lloyds Bank and FreedomPay24.4.2024 01:01:00 CEST | Press release

London, United Kingdom, April 23, 2024 (GLOBE NEWSWIRE) -- Less than a third (27%) of businesses are confident they offer seamless payments experiences.Almost two-thirds of businesses (59%) across Retail, Food & Beverages and Hospitality believe a good checkout experience offers the same competitive advantage as having the best products.Customer preference is the factor most likely to influence businesses’ investment in payment technologies. New research from Lloyds Bank and FreedomPay highlights the importance of UK businesses investing in new payment technology. Two-thirds (59%) of UK Retail, Food & Beverage (F&B) and Hospitality companies were found to already put payments at the heart of their customer experience strategy, reflecting the growing importance of payment options to customers. For retail-focused businesses, 59% believe that a good checkout experience is essential to building customer loyalty, with respondents believing it is as much a competitive advantage as having the

Millicom announces the re-issuance of its AGM and EGM Convening Notice23.4.2024 22:30:00 CEST | Press release

Millicom announces the re-issuance of its AGM and EGM Convening Notice Luxembourg, April 23, 2024 – Millicom today announced the re-issuance of the Convening Notice to its Annual General Meeting (“AGM”) and Extraordinary General Meeting (“EGM”) of Shareholders which will be held on May 23, 2024. The Convening Notice contains a rectified note to the AGM agenda item 20 (Share Repurchase Plan). All other items of the AGM and EGM remain unchanged. The Convening Notice is appended to this press release and available on the company’s website at: https://www.millicom.com/our-company/corporate-governance/shareholder-meetings/. AGM voting materials have been updated to reflect the rectified note. -END- For further information, please contact AGM/EGM Inquiries: Patrick Gill, Company Secretary +352 27 759 603 Maria Florencia Maiori, Senior Legal Counsel information@millicom.comPress: Sofia Corral, Director Corporate Communications press@millicom.comInvestors: Michel Morin, VP Investor Relations i

CNH announces signing of a €3.25 billion committed revolving credit facility23.4.2024 22:30:00 CEST | Press release

CNH announces signing of a €3.25 billion committed revolving credit facility Basildon, April 23, 2024 On April 19, 2024, CNH (NYSE: CNHI) signed a €3.25 billion committed revolving credit facility, intended for general corporate purposes of the Company. The facility, entered into with a group of 18 banks providing aggregate commitments in excess of €3.5 billion, has a 5-year tenor with two extension options of one year each, exercisable on the first and second anniversary of the signing date. It replaces an existing 5-year €4 billion facility due to mature in March 2026. The final size of the facility, set at €3.25 billion, aligns with reduced funding needs following the demerger of Iveco Group. The transaction confirms the strong support of a large panel of international key relationship banks for the Company. CNH Industrial (NYSE: CNHI) is a world-class equipment and services company. Driven by its purpose of Breaking New Ground, which centers on Innovation, Sustainability and Produc

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares23.4.2024 22:17:37 CEST | Press release

BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that it has commenced an underwritten public offering of $100 million of American Depositary Shares (“ADSs”), each representing one ordinary share. All of the ADSs are being offered by Centessa. In addition, Centessa intends to grant the underwriters a 30-day option to purchase up to an additional $15 million of ADSs offered in the public offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Goldman Sachs and Leerink Partners are acting as lead joint book-running managers for the proposed offering. Evercore ISI, Guggenheim Securities and BMO Capital Markets are also acting as joint book-running mana

HiddenA line styled icon from Orion Icon Library.Eye